{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:17:09Z","timestamp":1790299029388,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychiatr"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40211-024-00499-y","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T15:21:31Z","timestamp":1717514491000},"page":"163-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The relationship between schizophrenia or schizoaffective disorder and type\u00a01 diabetes mellitus: a\u00a0scoping review of observational studies","Die Beziehung zwischen Schizophrenie oder schizoaffektiver St\u00f6rung und Typ-1-Diabetes mellitus: eine Scoping-\u00dcbersicht von Beobachtungsstudien"],"prefix":"10.1007","volume":"38","author":[{"given":"Yi-Chun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-To","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"499_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/0963721410377601","volume":"19","author":"KH Karlsgodt","year":"2010","unstructured":"Karlsgodt\u00a0KH, Sun\u00a0D, Cannon\u00a0TD. Structural and Functional Brain Abnormalities in Schizophrenia. Curr Dir Psychol Sci. 2010;19:226\u201331.","journal-title":"Curr Dir Psychol Sci"},{"key":"499_CR2","doi-asserted-by":"publisher","first-page":"874","DOI":"10.4088\/JCP.v60n1211","volume":"60","author":"JD Evans","year":"1999","unstructured":"Evans\u00a0JD, Heaton\u00a0RK, Paulsen\u00a0JS, McAdams\u00a0LA, Heaton\u00a0SC, Jeste\u00a0DV. Schizoaffective disorder: a\u00a0form of schizophrenia or affective disorder? J\u00a0Clin Psychiatry. 1999;60:874\u201382.","journal-title":"J Clin Psychiatry"},{"key":"499_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2012.03.025","volume":"140","author":"PD Harvey","year":"2012","unstructured":"Harvey\u00a0PD, Heaton\u00a0RK, Carpenter\u00a0WT Jr., Green\u00a0MF, Gold\u00a0JM, Schoenbaum\u00a0M. Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophr Res. 2012;140:1\u20138.","journal-title":"Schizophr Res"},{"key":"499_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.schres.2013.02.036","volume":"147","author":"SM Cotton","year":"2013","unstructured":"Cotton\u00a0SM, Lambert\u00a0M, Schimmelmann\u00a0BG, Mackinnon\u00a0A, Gleeson\u00a0JFM, Berk\u00a0M, Hides\u00a0L, Chanen\u00a0AM, Scott\u00a0J, Schottle\u00a0D, McGorry\u00a0PD, Conus\u00a0P. Differences between first episode schizophrenia and schizoaffective disorder. Schizophr Res. 2013;147:169\u201374.","journal-title":"Schizophr Res"},{"key":"499_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/acps.12440","volume":"133","author":"BL Amann","year":"2016","unstructured":"Amann\u00a0BL, Canales-Rodriguez\u00a0EJ, Madre\u00a0M, Radua\u00a0J, Monte\u00a0G, Alonso-Lana\u00a0S, Landin-Romero\u00a0R, Moreno-Alcazar\u00a0A, Bonnin\u00a0CM, Sarro\u00a0S, Ortiz-Gil\u00a0J, Gomar\u00a0JJ, Moro\u00a0N, Fernandez-Corcuera\u00a0P, Goikolea\u00a0JM, Blanch\u00a0J, Salvador\u00a0R, Vieta\u00a0E, McKenna\u00a0PJ, Pomarol-Clotet\u00a0E. Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder. Acta Psychiatr Scand. 2016;133:23\u201333.","journal-title":"Acta Psychiatr Scand"},{"key":"499_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1176\/appi.ajp.2013.13010126","volume":"170","author":"EI Ivleva","year":"2013","unstructured":"Ivleva\u00a0EI, Bidesi\u00a0AS, Keshavan\u00a0MS, Pearlson\u00a0GD, Meda\u00a0SA, Dodig\u00a0D, Moates\u00a0AF, Lu\u00a0H, Francis\u00a0AN, Tandon\u00a0N, Schretlen\u00a0DJ, Sweeney\u00a0JA, Clementz\u00a0BA, Tamminga\u00a0CA. Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry. 2013;170:1285\u201396.","journal-title":"Am J Psychiatry"},{"key":"499_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00406-021-01337-w","volume":"272","author":"S Walther","year":"2022","unstructured":"Walther\u00a0S, Lefebvre\u00a0S, Conring\u00a0F, Gangl\u00a0N, Nadesalingam\u00a0N, Alexaki\u00a0D, Wuthrich\u00a0F, Ruter\u00a0M, Viher\u00a0PV, Federspiel\u00a0A, Wiest\u00a0R, Stegmayer\u00a0K. Limbic links to paranoia: increased resting-state functional connectivity between amygdala, hippocampus and orbitofrontal cortex in schizophrenia patients with paranoia. Eur Arch Psychiatry Clin Neurosci. 2022;272:1021\u201332.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"499_CR8","doi-asserted-by":"publisher","first-page":"e05545","DOI":"10.1016\/j.heliyon.2020.e05545","volume":"6","author":"R Nawaz","year":"2020","unstructured":"Nawaz\u00a0R, Gul\u00a0S, Amin\u00a0R, Huma\u00a0T, Al Mughairbi\u00a0F. Overview of schizophrenia research and treatment in Pakistan. Heliyon. 2020;6:e5545.","journal-title":"Heliyon"},{"issue":"44","key":"499_CR9","first-page":"1195","volume":"2018","author":"FJ Charlson","year":"2016","unstructured":"Charlson\u00a0FJ, Ferrari\u00a0AJ, Santomauro\u00a0DF, Diminic\u00a0S, Stockings\u00a0E, Scott\u00a0JG, McGrath\u00a0JJ, Whiteford\u00a0HA. Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study. Schizophr Bull. 2016;2018(44):1195\u2013203.","journal-title":"Schizophr Bull"},{"key":"499_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/1359786810382149","volume":"24","author":"HJ Wildgust","year":"2010","unstructured":"Wildgust\u00a0HJ, Hodgson\u00a0R, Beary\u00a0M. The paradox of premature mortality in schizophrenia: new research questions. J\u00a0Psychopharmacol. 2010;24:9\u201315.","journal-title":"J Psychopharmacol"},{"key":"499_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/1359786810384639","volume":"24","author":"HJ Wildgust","year":"2010","unstructured":"Wildgust\u00a0HJ, Beary\u00a0M. Are there modifiable risk factors which will reduce the excess mortality in schizophrenia? J\u00a0Psychopharmacol. 2010;24:37\u201350.","journal-title":"J Psychopharmacol"},{"key":"499_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.schres.2019.05.028","volume":"217","author":"HC van Mierlo","year":"2020","unstructured":"van Mierlo\u00a0HC, Schot\u00a0A, Boks\u00a0MPM, de Witte\u00a0LD. The association between schizophrenia and the immune system: Review of the evidence from unbiased \u2018omic-studies. Schizophr Res. 2020;217:114\u201323.","journal-title":"Schizophr Res"},{"key":"499_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.reprotox.2010.09.006","volume":"31","author":"RR Dietert","year":"2011","unstructured":"Dietert\u00a0RR. Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer. Reprod Toxicol. 2011;31:319\u201326.","journal-title":"Reprod Toxicol"},{"key":"499_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.schres.2013.07.029","volume":"150","author":"A Ezeoke","year":"2013","unstructured":"Ezeoke\u00a0A, Mellor\u00a0A, Buckley\u00a0P, Miller\u00a0B. A\u00a0systematic, quantitative review of blood autoantibodies in schizophrenia. Schizophr Res. 2013;150:245\u201351.","journal-title":"Schizophr Res"},{"key":"499_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1017\/S2045796016000561","volume":"26","author":"S Tiosano","year":"2017","unstructured":"Tiosano\u00a0S, Farhi\u00a0A, Watad\u00a0A, Grysman\u00a0N, Stryjer\u00a0R, Amital\u00a0H, Comaneshter\u00a0D, Cohen\u00a0AD, Amital\u00a0D. Schizophrenia among patients with systemic lupus erythematosus: population-based cross-sectional study. Epidemiol Psychiatr Sci. 2017;26:424\u20139.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"499_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/oxfordjournals.schbul.a033407","volume":"25","author":"RJ Oken","year":"1999","unstructured":"Oken\u00a0RJ, Schulzer\u00a0M. At issue: schizophrenia and rheumatoid arthritis: the negative association revisited. Schizophr Bull. 1999;25:625\u201338.","journal-title":"Schizophr Bull"},{"key":"499_CR17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/archpsyc.64.8.894","volume":"64","author":"H Juvonen","year":"2007","unstructured":"Juvonen\u00a0H, Reunanen\u00a0A, Haukka\u00a0J, Muhonen\u00a0M, Suvisaari\u00a0J, Arajarvi\u00a0R, Partonen\u00a0T, Lonnqvist\u00a0J. Incidence of schizophrenia in a\u00a0nationwide cohort of patients with type\u00a01 diabetes mellitus. Arch Gen Psychiatry. 2007;64:894\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"499_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.biopsych.2018.06.016","volume":"85","author":"AE Cullen","year":"2019","unstructured":"Cullen\u00a0AE, Holmes\u00a0S, Pollak\u00a0TA, Blackman\u00a0G, Joyce\u00a0DW, Kempton\u00a0MJ, Murray\u00a0RM, McGuire\u00a0P, Mondelli\u00a0V. Associations Between Non-neurological Autoimmune Disorders and Psychosis: A\u00a0Meta-analysis. Biol Psychiatry. 2019;85:35\u201348.","journal-title":"Biol Psychiatry"},{"key":"499_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0920-9964(92)90001-L","volume":"6","author":"WW Eaton","year":"1992","unstructured":"Eaton\u00a0WW, Hayward\u00a0C, Ram\u00a0R. Schizophrenia and rheumatoid arthritis: a\u00a0review. Schizophr Res. 1992;6:181\u201392.","journal-title":"Schizophr Res"},{"key":"499_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/schbul\/17.4.669","volume":"17","author":"S Vinogradov","year":"1991","unstructured":"Vinogradov\u00a0S, Gottesman\u00a0MHW II, Nicol\u00a0S. Negative association between schizophrenia and rheumatoid arthritis. Schizophr Bull. 1991;17:669\u201378.","journal-title":"Schizophr Bull"},{"key":"499_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/intimm\/dxs049","volume":"24","author":"D Bending","year":"2012","unstructured":"Bending\u00a0D, Zaccone\u00a0P, Cooke\u00a0A. Inflammation and type one diabetes. Int Immunol. 2012;24:339\u201346.","journal-title":"Int Immunol"},{"key":"499_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s11892-014-0520-2","volume":"14","author":"R Streisand","year":"2014","unstructured":"Streisand\u00a0R, Monaghan\u00a0M. Young children with type\u00a01 diabetes: challenges, research, and future directions. Curr Diab Rep. 2014;14:520.","journal-title":"Curr Diab Rep"},{"key":"499_CR23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/0145721712445216","volume":"38","author":"R Whittemore","year":"2012","unstructured":"Whittemore\u00a0R, Jaser\u00a0S, Chao\u00a0A, Jang\u00a0M, Grey\u00a0M. Psychological experience of parents of children with type\u00a01 diabetes: a\u00a0systematic mixed-studies review. Diabetes Educ. 2012;38:562\u201379.","journal-title":"Diabetes Educ"},{"key":"499_CR24","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.2337\/dc14-1140","volume":"37","author":"JL Chiang","year":"2014","unstructured":"Chiang\u00a0JL, Kirkman\u00a0MS, Laffel\u00a0LM, Peters\u00a0AL. Type\u00a01 diabetes through the life span: a\u00a0position statement of the American Diabetes Association. Diabetes Care. 2014;37:2034\u201354.","journal-title":"Diabetes Care"},{"key":"499_CR25","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.2337\/diacare.26.4.1052","volume":"26","author":"KS Bryden","year":"2003","unstructured":"Bryden\u00a0KS, Dunger\u00a0DB, Mayou\u00a0RA, Peveler\u00a0RC, Neil\u00a0HA. Poor prognosis of young adults with type\u00a01 diabetes: a\u00a0longitudinal study. Diabetes Care. 2003;26:1052\u20137.","journal-title":"Diabetes Care"},{"key":"499_CR26","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.2337\/diacare.24.7.1286","volume":"24","author":"AM Delamater","year":"2001","unstructured":"Delamater\u00a0AM, Jacobson\u00a0AM, Anderson\u00a0B, Cox\u00a0D, Fisher\u00a0L, Lustman\u00a0P, Rubin\u00a0R, Wysocki\u00a0T. Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group. Diabetes Care. 2001;24:1286\u201392.","journal-title":"Diabetes Care"},{"key":"499_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4103\/2230-8210.180002","volume":"20","author":"H Vaseghi","year":"2016","unstructured":"Vaseghi\u00a0H, Jadali\u00a0Z. Th1\/Th2 cytokines in Type\u00a01 diabetes: Relation to duration of disease and gender. Indian J Endocrinol Metab. 2016;20:312\u20136.","journal-title":"Indian J Endocrinol Metab"},{"key":"499_CR28","first-page":"268","volume":"46","author":"B Avgustin","year":"2005","unstructured":"Avgustin\u00a0B, Wraber\u00a0B, Tavcar\u00a0R. Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia. Croat Med\u00a0J. 2005;46:268\u201374.","journal-title":"Croat Med J"},{"key":"499_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000111535","volume":"56","author":"KS Na","year":"2007","unstructured":"Na\u00a0KS, Kim\u00a0YK. Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia. Neuropsychobiology. 2007;56:55\u201363.","journal-title":"Neuropsychobiology"},{"key":"499_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cellimm.2012.11.001","volume":"280","author":"S Shao","year":"2012","unstructured":"Shao\u00a0S, He\u00a0F, Yang\u00a0Y, Yuan\u00a0G, Zhang\u00a0M, Yu\u00a0X. Th17 cells in type\u00a01 diabetes. Cell Immunol. 2012;280:16\u201321.","journal-title":"Cell Immunol"},{"key":"499_CR31","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1093\/schbul\/sbu049","volume":"40","author":"M Debnath","year":"2014","unstructured":"Debnath\u00a0M, Berk\u00a0M. Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications. Schizophr Bull. 2014;40:1412\u201321.","journal-title":"Schizophr Bull"},{"key":"499_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/YPG.0000000000000315","volume":"32","author":"M Subbanna","year":"2022","unstructured":"Subbanna\u00a0M, Shivakumar\u00a0V, Bhalerao\u00a0G, Varambally\u00a0S, Venkatasubramanian\u00a0G, Debnath\u00a0M. Variants of Th17 pathway-related genes influence brain morphometric changes and the risk of schizophrenia through epistatic interactions. Psychiatr Genet. 2022;32:146\u201355.","journal-title":"Psychiatr Genet"},{"key":"499_CR33","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.2337\/db10-1643","volume":"60","author":"S Arif","year":"2011","unstructured":"Arif\u00a0S, Moore\u00a0F, Marks\u00a0K, Bouckenooghe\u00a0T, Dayan\u00a0CM, Planas\u00a0R, Vives-Pi\u00a0M, Powrie\u00a0J, Tree\u00a0T, Marchetti\u00a0P, Huang\u00a0GC, Gurzov\u00a0EN, Pujol-Borrell\u00a0R, Eizirik\u00a0DL, Peakman\u00a0M. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated beta-cell death. Diabetes. 2011;60:2112\u20139.","journal-title":"Diabetes"},{"key":"499_CR34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/eji.200838475","volume":"39","author":"N Martin-Orozco","year":"2009","unstructured":"Martin-Orozco\u00a0N, Chung\u00a0Y, Chang\u00a0SH, Wang\u00a0YH, Dong\u00a0C. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol. 2009;39:216\u201324.","journal-title":"Eur J Immunol"},{"issue":"Suppl 22","key":"499_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/pedi.12388","volume":"17","author":"A Pugliese","year":"2016","unstructured":"Pugliese\u00a0A. Insulitis in the pathogenesis of type\u00a01 diabetes. Pediatr Diabetes. 2016;17(Suppl 22):31\u20136.","journal-title":"Pediatr Diabetes"},{"key":"499_CR36","doi-asserted-by":"crossref","unstructured":"Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Borglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Bottcher Y, Olesen J, Breuer R, Moller HJ, Giegling I, Rasmussen HB, Timm S, Mattheisen M, Bitter I, Rethelyi JM, Magnusdottir BB, Sigmundsson T, Olason P, Masson G, Gulcher JR, Haraldsson M, Fossdal R, Thorgeirsson TE, Thorsteinsdottir U, Ruggeri M, Tosato S, Franke B, Strengman E, Kiemeney LA, Genetic R, Outcome in P, Melle I, Djurovic S, Abramova L, Kaleda V, Sanjuan J, de Frutos R, Bramon E, Vassos E, Fraser G, Ettinger U, Picchioni M, Walker N, Toulopoulou T, Need AC, Ge D, Yoon JL, Shianna KV, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Carracedo A, Arango C, Costas J, Jonsson EG, Terenius L, Agartz I, Petursson H, Nothen MM, Rietschel M, Matthews PM, Muglia P, Peltonen L, St Clair D, Goldstein DB, Stefansson K, Collier DA. Common variants conferring risk of schizophrenia. Nature. 2009;460:744\u2013747.","DOI":"10.1038\/nature08186"},{"key":"499_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.schres.2014.09.004","volume":"159","author":"S Stringer","year":"2014","unstructured":"Stringer\u00a0S, Kahn\u00a0RS, de Witte\u00a0LD, Ophoff\u00a0RA, Derks\u00a0EM. Genetic liability for schizophrenia predicts risk of immune disorders. Schizophr Res. 2014;159:347\u201352.","journal-title":"Schizophr Res"},{"key":"499_CR38","doi-asserted-by":"publisher","first-page":"101319","DOI":"10.1016\/j.diabet.2022.101319","volume":"48","author":"MH Chen","year":"2022","unstructured":"Chen\u00a0MH, Tsai\u00a0SJ, Bai\u00a0YM, Huang\u00a0KL, Su\u00a0TP, Chen\u00a0TJ, Hsu\u00a0JW. Type\u00a01 diabetes mellitus and risks of major psychiatric disorders: A\u00a0nationwide population-based cohort study. Diabetes Metab. 2022;48:101319.","journal-title":"Diabetes Metab"},{"key":"499_CR39","first-page":"245","volume":"41","author":"K Melkersson","year":"2020","unstructured":"Melkersson\u00a0K. Schizophrenia- or schizoaffective disorder diagnosis and the risk for subsequent type\u00a01- or type\u00a02 diabetes mellitus: a\u00a0Swedish nationwide register-based cohort study. Neuro Endocrinol Lett. 2020;41:245\u201354.","journal-title":"Neuro Endocrinol Lett"},{"key":"499_CR40","first-page":"125","volume":"40","author":"K Melkersson","year":"2019","unstructured":"Melkersson\u00a0K, Wernroth\u00a0ML. Type\u00a01 diabetes mellitus and the risk for schizophrenia or schizoaffective disorder: a\u00a0Swedish nationwide register-based cohort study. Neuro Endocrinol Lett. 2019;40:125\u201334.","journal-title":"Neuro Endocrinol Lett"},{"key":"499_CR41","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/pedi.12469","volume":"18","author":"MN Cooper","year":"2017","unstructured":"Cooper\u00a0MN, Lin\u00a0A, Alvares\u00a0GA, de Klerk\u00a0NH, Jones\u00a0TW, Davis\u00a0EA. Psychiatric disorders during early adulthood in those with childhood onset type\u00a01 diabetes: Rates and clinical risk factors from population-based follow-up. Pediatr Diabetes. 2017;18:599\u2013606.","journal-title":"Pediatr Diabetes"},{"key":"499_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.psychres.2017.09.071","volume":"258","author":"L Cremaschi","year":"2017","unstructured":"Cremaschi\u00a0L, Kardell\u00a0M, Johansson\u00a0V, Isgren\u00a0A, Sellgren\u00a0CM, Altamura\u00a0AC, Hultman\u00a0CM, Landen\u00a0M. Prevalences of autoimmune diseases in schizophrenia, bipolar I and\u00a0II disorder, and controls. Psychiatry Res. 2017;258:9\u201314.","journal-title":"Psychiatry Res"},{"key":"499_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00406-013-0436-x","volume":"264","author":"D Schoepf","year":"2014","unstructured":"Schoepf\u00a0D, Uppal\u00a0H, Potluri\u00a0R, Heun\u00a0R. Physical comorbidity and its relevance on mortality in schizophrenia: a\u00a0naturalistic 12-year follow-up in general hospital admissions. Eur Arch Psychiatry Clin Neurosci. 2014;264:3\u201328.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"499_CR44","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1192\/bjp.bp.111.092098","volume":"200","author":"SJ Chen","year":"2012","unstructured":"Chen\u00a0SJ, Chao\u00a0YL, Chen\u00a0CY, Chang\u00a0CM, Wu\u00a0EC, Wu\u00a0CS, Yeh\u00a0HH, Chen\u00a0CH, Tsai\u00a0HJ. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br J Psychiatry. 2012;200:374\u201380.","journal-title":"Br J Psychiatry"},{"key":"499_CR45","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1399-5618.2010.00853.x","volume":"12","author":"WW Eaton","year":"2010","unstructured":"Eaton\u00a0WW, Pedersen\u00a0MG, Nielsen\u00a0PR, Mortensen\u00a0PB. Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord. 2010;12:638\u201346.","journal-title":"Bipolar Disord"},{"key":"499_CR46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(18)31811-7","volume":"392","author":"M Basina","year":"2018","unstructured":"Basina\u00a0M, Maahs\u00a0DM. Age at type\u00a01 diabetes onset: a\u00a0new risk factor and call for focused treatment. Lancet. 2018;392:453\u20134.","journal-title":"Lancet"},{"key":"499_CR47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","volume":"27","author":"M Solmi","year":"2022","unstructured":"Solmi\u00a0M, Radua\u00a0J, Olivola\u00a0M, Croce\u00a0E, Soardo\u00a0L, Salazar de Pablo\u00a0G, Shin\u00a0IJ, Kirkbride\u00a0JB, Jones\u00a0P, Kim\u00a0JH, Kim\u00a0JY, Carvalho\u00a0AF, Seeman\u00a0MV, Correll\u00a0CU, Fusar-Poli\u00a0P. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022;27:281\u201395.","journal-title":"Mol Psychiatry"},{"issue":"W264","key":"499_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher\u00a0D, Liberati\u00a0A, Tetzlaff\u00a0J, Altman\u00a0DG, Group\u00a0P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(W264):264\u20139.","journal-title":"Ann Intern Med"},{"key":"499_CR49","first-page":"2127","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn\u00a0Z, Barker\u00a0TH, Moola\u00a0S, Tufanaru\u00a0C, Stern\u00a0C, McArthur\u00a0A, Stephenson\u00a0M, Aromataris\u00a0E. Methodol Qual Case Ser Studies: Introd To Jbi Crit Apprais Tool Jbi Evid Synth. 2020;18:2127\u201333.","journal-title":"Methodol Qual Case Ser Studies: Introd To Jbi Crit Apprais Tool Jbi Evid Synth"},{"key":"499_CR50","doi-asserted-by":"publisher","first-page":"14979","DOI":"10.1038\/s41598-023-42217-8","volume":"13","author":"S Kuraeiad","year":"2023","unstructured":"Kuraeiad\u00a0S, Kotepui\u00a0KU, Masangkay\u00a0FR, Mahittikorn\u00a0A, Kotepui\u00a0M. Association of uric acid levels with severity of Plasmodium infections: a\u00a0systematic review and meta-analysis. Sci Rep. 2023;13:14979.","journal-title":"Sci Rep"},{"key":"499_CR51","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","volume":"168","author":"ME Benros","year":"2011","unstructured":"Benros\u00a0ME, Nielsen\u00a0PR, Nordentoft\u00a0M, Eaton\u00a0WW, Dalton\u00a0SO, Mortensen\u00a0PB. Autoimmune diseases and severe infections as risk factors for schizophrenia: a\u00a030-year population-based register study. Am J Psychiatry. 2011;168:1303\u201310.","journal-title":"Am J Psychiatry"},{"key":"499_CR52","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","volume":"163","author":"WW Eaton","year":"2006","unstructured":"Eaton\u00a0WW, Byrne\u00a0M, Ewald\u00a0H, Mors\u00a0O, Chen\u00a0CY, Agerbo\u00a0E, Mortensen\u00a0PB. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006;163:521\u20138.","journal-title":"Am J Psychiatry"},{"key":"499_CR53","doi-asserted-by":"publisher","first-page":"204512532211360","DOI":"10.1177\/20451253221136021","volume":"12","author":"O Corbeil","year":"2022","unstructured":"Corbeil\u00a0O, Essiambre\u00a0AM, Bechard\u00a0L, Roy\u00a0AA, Huot-Lavoie\u00a0M, Brodeur\u00a0S, Chandrasena\u00a0R, Theriault\u00a0C, Crocker\u00a0C, Melun\u00a0JP, Tibbo\u00a0P, Demers\u00a0MF, Roy\u00a0MA. Real-life effectiveness of transitioning from paliperidone palmitate 1\u2011monthly to paliperidone palmitate 3\u2011monthly long-acting injectable formulation. Ther Adv Psychopharmacol. 2022;12:20451253221136021.","journal-title":"Ther Adv Psychopharmacol"},{"key":"499_CR54","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.schres.2016.07.020","volume":"176","author":"P Hallford","year":"2016","unstructured":"Hallford\u00a0P, Clair\u00a0DS, Halley\u00a0L, Mustard\u00a0C, Wei\u00a0J. A\u00a0study of type\u20111 diabetes associated autoantibodies in schizophrenia. Schizophr Res. 2016;176:186\u201390.","journal-title":"Schizophr Res"},{"key":"499_CR55","doi-asserted-by":"publisher","first-page":"958430","DOI":"10.3389\/fimmu.2022.958430","volume":"13","author":"A Starosz","year":"2022","unstructured":"Starosz\u00a0A, Jamiolkowska-Sztabkowska\u00a0M, Glowinska-Olszewska\u00a0B, Moniuszko\u00a0M, Bossowski\u00a0A, Grubczak\u00a0K. Immunological balance between Treg and Th17 lymphocytes as a\u00a0key element of type\u00a01 diabetes progression in children. Front Immunol. 2022;13:958430.","journal-title":"Front Immunol"},{"key":"499_CR56","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbi.2020.06.014","volume":"91","author":"X Liu","year":"2021","unstructured":"Liu\u00a0X, Nudel\u00a0R, Thompson\u00a0WK, Appadurai\u00a0V, Schork\u00a0AJ, Buil\u00a0A, Rasmussen\u00a0S, Allesoe\u00a0RL, Werge\u00a0T, Mors\u00a0O, Borglum\u00a0AD, Hougaard\u00a0DM, Mortensen\u00a0PB, Nordentoft\u00a0M, Benros\u00a0ME. Genetic factors underlying the bidirectional relationship between autoimmune and mental disorders\u2014Findings from a\u00a0Danish population-based study. Brain Behav Immun. 2021;91:10\u201323.","journal-title":"Brain Behav Immun"},{"key":"499_CR57","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40264-017-0543-0","volume":"40","author":"L Hirsch","year":"2017","unstructured":"Hirsch\u00a0L, Yang\u00a0J, Bresee\u00a0L, Jette\u00a0N, Patten\u00a0S, Pringsheim\u00a0T. Second-Generation Antipsychotics and Metabolic Side Effects: A\u00a0Systematic Review of Population-Based Studies. Drug Saf. 2017;40:771\u201381.","journal-title":"Drug Saf"},{"key":"499_CR58","doi-asserted-by":"crossref","unstructured":"Liu Y, Li Z, Zhang M, Deng Y, Yi Z, Shi T. Exploring the pathogenetic association between schizophrenia and type\u00a02 diabetes mellitus diseases based on pathway analysis. BMC Med Genomics. 2013;6 Suppl 1:S17.","DOI":"10.1186\/1755-8794-6-S1-S17"},{"key":"499_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41398-022-01817-0","volume":"12","author":"G Fanelli","year":"2022","unstructured":"Fanelli\u00a0G, Franke\u00a0B, De Witte\u00a0W, Ruisch\u00a0IH, Haavik\u00a0J, van Gils\u00a0V, Jansen\u00a0WJ, Vos\u00a0SJB, Lind\u00a0L, Buitelaar\u00a0JK, Banaschewski\u00a0T, Dalsgaard\u00a0S, Serretti\u00a0A, Mota\u00a0NR, Poelmans\u00a0G, Bralten\u00a0J. Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders. Transl Psychiatry. 2022;12:59.","journal-title":"Transl Psychiatry"}],"container-title":["neuropsychiatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40211-024-00499-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40211-024-00499-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40211-024-00499-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:18:00Z","timestamp":1732609080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40211-024-00499-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["499"],"URL":"https:\/\/doi.org\/10.1007\/s40211-024-00499-y","relation":{},"ISSN":["0948-6259","2194-1327"],"issn-type":[{"value":"0948-6259","type":"print"},{"value":"2194-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"23 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.\u00a0Liu, Y.\u00a0Liao, and K.\u00a0Lin declared that they have no known financial, professional, or contractual competing interests that could influence the study design, writing of the paper, or presentation of our work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}